Cureline’s Year-End Sale: Up to 30% Off
Isabel Felix-chan
on
December 7, 2023
Scientist.com is now listing Cureline’s year-end promotion, which includes up to 30% off on select banked inventory samples until December 31, 2023. Find discounted pricing off cells from Solid Oncology and Hematology. Request Cureline’s products here.
About Cureline
Since its inception in 2003, Cureline has consistently emerged as a premier option for the analysis of human biospecimens. With a track record of aiding over 600 clients in the completion of over 4,000 projects, Cureline specializes in biomarker R&D, companion diagnostics, clinical research, and developmental processes. The depth of their expertise enables continuous expansion into new therapeutic areas, solidifying Cureline’s position as a trusted leader in the field.
Up to 30% Off Banked Inventory Samples
Cureline is offering Scientist.com customers up to 30% off their banked inventory samples, including solid oncology and hematology cells. Be sure to include Cureline in your request here through December 31, 2023 to receive this discount.
View Cureline’s promotional products in the table below.
| Cureline Product Number | Indication | Product Name |
|---|---|---|
| 100002008 | Bladder cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100002018 | Bladder cancer | PBMC, viable cells (5 M/tube) |
| 100007008 | Brain tumor: Glioblastoma | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100007018 | Brain tumor: Glioblastoma | PBMC, viable cells (5 M/tube) |
| 100008008 | Breast Carcinoma | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100008018 | Breast Carcinoma | PBMC, viable cells (5 M/tube) |
| 100011008 | Cervical cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100011018 | Cervical cancer | PBMC, viable cells (5 M/tube) |
| 100013008 | Colorectal cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100013018 | Colorectal cancer | PBMC, viable cells (5 M/tube) |
| 100014008 | Endometrial cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100014018 | Endometrial cancer | PBMC, viable cells (5 M/tube) |
| 100015008 | Esophageal cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100015018 | Esophageal cancer | PBMC, viable cells (5 M/tube) |
| 100024018 | Hodgkin’s lymphoma | PBMC, viable cells (5 M/tube) |
| 100025008 | Kidney (renal cell) cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100025018 | Kidney (renal cell) cancer | PBMC, viable cells (5 M/tube) |
| 100026008 | Head and Neck (H&N) carcinoma | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100026018 | Head and Neck (H&N) carcinoma | PBMC, viable cells (5 M/tube) |
| 100027018 | Hepatocellular carcinoma (HCC) | PBMC, viable cells (5 M/tube) |
| 100028008 | Lung cancer, non-small cell (NSCLC) | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100028018 | Lung cancer, non-small cell (NSCLC) | PBMC, viable cells (5 M/tube) |
| 100031008 | non-Hodgkin’s lymphoma (DLBCL) | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100031018 | non-Hodgkin’s lymphoma (DLBCL) | PBMC, viable cells (5 M/tube) |
| 100032008 | Melanoma | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100032018 | Melanoma | PBMC, viable cells (5 M/tube) |
| 100037008 | Ovarian adenocarcinoma | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100037018 | Ovarian adenocarcinoma | PBMC, viable cells (5 M/tube) |
| 100040008 | Pancreatic cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100040018 | Pancreatic cancer | PBMC, viable cells (5 M/tube) |
| 100043008 | Prostate cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100043018 | Prostate cancer | PBMC, viable cells (5 M/tube) |
| 100047008 | Stomach (gastric) cancer | Dissociated Tumor Cells (DTC), 1 million cells/tube |
| 100047018 | Stomach (gastric) cancer | PBMC, viable cells (5 M/tube) |
| 100048018 | Normal Donor | PBMC, viable cells (5 M/tube) |
| 200001018 | Acute lymphocytic leukemia (ALL) | PBMC, viable cells (5 M/tube) |
| 200001019 | Acute lymphocytic leukemia (ALL) | PBMC, viable cells (10 M/tube) |
| 200001022 | Acute lymphocytic leukemia (ALL) | BMMC, viable cells (5 M/tube) |
| 200001023 | Acute lymphocytic leukemia (ALL) | BMMC, viable cells (10 M/tube) |
| 200002018 | Acute myeloid leukemia (AML) | PBMC, viable cells (5 M/tube) |
| 200002019 | Acute myeloid leukemia (AML) | PBMC, viable cells (10 M/tube) |
| 200002022 | Acute myeloid leukemia (AML) | BMMC, viable cells (5 M/tube) |
| 200002023 | Acute myeloid leukemia (AML) | BMMC, viable cells (10 M/tube) |
| 200003018 | Chronic lymphocytic leukemia (CLL) | PBMC, viable cells (5 M/tube) |
| 200003019 | Chronic lymphocytic leukemia (CLL) | PBMC, viable cells (10 M/tube) |
| 200003022 | Chronic lymphocytic leukemia (CLL) | BMMC, viable cells (5 M/tube) |
| 200003023 | Chronic lymphocytic leukemia (CLL) | BMMC, viable cells (10 M/tube) |
| 200004018 | Chronic myeloid leukemia (CML) | PBMC, viable cells (5 M/tube) |
| 200004019 | Chronic myeloid leukemia (CML) | PBMC, viable cells (10 M/tube) |
| 200004022 | Chronic myeloid leukemia (CML) | BMMC, viable cells (5 M/tube) |
| 200004023 | Chronic myeloid leukemia (CML) | BMMC, viable cells (10 M/tube) |
| 200006018 | Multiple myeloma (MM) | PBMC, viable cells (5 M/tube) |
| 200006022 | Multiple myeloma (MM) | BMMC, viable cells (5 M/tube) |
| 200006023 | Multiple myeloma (MM) | BMMC, viable cells (10 M/tube) |
| 200007018 | Myelodysplastic syndrome (MDS) | PBMC, viable cells (5 M/tube) |
| 200007022 | Myelodysplastic syndrome (MDS) | BMMC, viable cells (5 M/tube) |
| 200007023 | Myelodysplastic syndrome (MDS) | BMMC, viable cells (10 M/tube) |